网状发育不全:临床表现、移植与结局的国际调查
该国际回顾性调查收集了欧洲、亚洲和北美中心1982年至2011年出生的32例网状发育不全(RD)患者资料。30例(94%)在4周龄内就诊,21/31例移植后存活,平均随访7.9年;移植后6个月以上死亡者均因供者髓系植入失败导致持续或复发性粒细胞缺乏。无预处理时HSCT不能克服粒细胞缺乏,需含清髓成分的方案以实现稳定淋巴髓系植入。
要点
- RD临床三联征为严重联合免疫缺陷、粒细胞缺乏和感音神经性耳聋。
- 32例中30例(94%)在4周龄内就诊,HSCT是唯一治愈手段。
- 21/31例移植后存活,平均随访7.9年;晚期死亡均与供者髓系植入失败所致粒细胞缺乏相关。
核心结论
- HSCT可治愈RD,但需含清髓成分的预处理以实现稳定淋巴髓系植入;长期存活可在混合嵌合状态下实现,但应追求高水平供者髓系植入以避免移植后中性粒细胞减少。
研究设计与样本
- 回顾性数据收集,来自欧洲、亚洲和北美中心,共32例1982年至2011年出生的RD患者。
主要发现
- 就诊年龄小于4周者30/32例(94%)。
- 移植物来源:错配家族供者17例(55%),相合家族供者6例(19%),无关骨髓或脐带血供者8例(26%)。
- 13例接受了二次或三次移植。
- 移植后31例中21例存活,平均随访7.9年(范围0.6-23.6年)。
- 移植后6个月以上死亡的所有患者均因供者髓系植入失败导致持续或复发性粒细胞缺乏。
关键数值与推荐
- 无预处理时HSCT不能克服粒细胞缺乏。
- 预处理方案需包含清髓成分以实现稳定淋巴髓系植入。
- 与其他SCID类型相比,RD在就诊年龄、感染并发症的发生时间和类型以及HSCT前预处理需求方面存在显著差异。
临床怎么用
- 作者指出,尽管混合嵌合状态下可实现长期存活,但应追求高水平供者髓系植入以避免移植后中性粒细胞减少。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Reticular dysgenesis (RD) is a rare congenital disorder defined clinically by the combination of severe combined immunodeficiency (SCID), agranulocytosis, and sensorineural deafness. Mutations in the gene encoding adenylate kinase 2 were identified to cause the disorder. Hematopoietic stem cell transplantation (HSCT) is the only option to cure this otherwise fatal disease. Retrospective data on clinical presentation, genetics, and outcome of HSCT were collected from centers in Europe, Asia, and North America for a total of 32 patients born between 1982 and 2011. Age at presentation was <4 weeks in 30 of 32 patients (94%). Grafts originated from mismatched family donors in 17 patients (55%), from matched family donors in 6 patients (19%), and from unrelated marrow or umbilical cord blood donors in 8 patients (26%). Thirteen patients received secondary or tertiary transplants. After transplantation, 21 of 31 patients were reported alive at a mean follow-up of 7.9 years (range: 0.6-23.6 years). All patients who died beyond 6 months after HSCT had persistent or recurrent agranulocytosis due to failure of donor myeloid engraftment. In the absence of conditioning, HSCT was ineffective to overcome agranulocytosis, and inclusion of myeloablative components in the conditioning regimens was required to achieve stable lymphomyeloid engraftment. In comparison with other SCID entities, considerable differences were noted regarding age at presentation, onset, and type of infectious complications, as well as the requirement of conditioning prior to HSCT. Although long-term survival is possible in the presence of mixed chimerism, high-level donor myeloid engraftment should be targeted to avoid posttransplant neutropenia.
引用
- Hoenig M, Lagresle-Peyrou C, Pannicke U, et al. Reticular dysgenesis: international survey on clinical presentation, transplantation, and outcome. Blood. 2017. PMID: 28331055. doi:10.1182/blood-2016-11-745638
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。